| 31 |
Copper-chelation-induced ratiometric fluorescence response for sensitive ratiometric detection of zoledronic acid: implications for monitoring in renal impairment |
قسم الكيمياء التحليلية الصيدلية |
2025 |
| 32 |
Crystal structure and quantum chemical calculations of 2-(2'-oxospiro[1,3-dioxolane-2,3'-indol]-1'(2'H)-yl)acetohydrazide |
قسم الكيمياء الدوائية |
2025 |
| 33 |
Design and synthesis of 5-substituted-2-Iminothiazolidin-4-one Derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa virulence factors: An integrated study of molecular docking, dynamics, and biological assays |
قسم الكيمياء الدوائية |
2025 |
| 34 |
Design, synthesis, and antiproliferative activity of new 2-amino-pyrano[3,2-c]quinoline-3- carbonitriles as potential EGFR, BRAFV600E, and HER-2 inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 35 |
Design, synthesis, and antiproliferative activity of new 5-ethylsulfonylindazole- 3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 36 |
Design, Synthesis, and Antiproliferative Activity of Novel Indole/1,2,4-Triazole Hybrids as Tubulin Polymerization Inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 37 |
Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 38 |
Design, synthesis, and characterization of novel 5- ethylsulfonyl-indazole-3-carboxamides as dual VEGFR-2 and EGFR inhibitors: apoptotic antiproliferative and immunomodulatory evaluations |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 39 |
Design, synthesis, and computational studies of novel pyrazoline-based dual EGFR/HER-2 inhibitors with apoptotic antiproliferative activity |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 40 |
Design, synthesis, and structural elucidation of ethyl 2-amino-5-oxo-4-aryl-4H-pyrano[3,2-c] quinoline-3-carboxylates as dual EGFR/HER-2 inhibitors endowed with antiproliferative activity |
قسم الكيمياء العضوية الصيدلية |
2025 |
